India, June 26 -- NORTH CENTRAL RAILWAY has issued a tender notice titled "Inj. Insulin Glulisine (Monocomponent Insulin Glulisine) 100 Units/Ml, Pfs/Cartridge (One Pen and 50 Needles Free with 50 Cartridges) Per Unit" with the tender reference no.: 82255227A.
The tender details are as follows: Inj. Insulin Glulisine (Monocomponent Insulin Glulisine) 100 Units/Ml, Pfs/Cartrid Ge (One Pen and 50 Needles Free with 50 Cartridges) Per Unit (Item No. 2100 of Ami 2025-26) (Bran D - Apidra, Marketed by M/S. Sanofi India Limited) ]
Contract Category: Expenditure
The expression of interest should be received by Aug. 8.
For more information, contact NORTH CENTRAL RAILWAY, Address: STORES/NORTH CENTRAL RLY Uttar Pradesh, Allahabad - 211011.
City...